Aker BioMarine Logo

Aker BioMarine

ISIN: NO0010886625 | Ticker: AKBM | LEI: 549300MU8WPXD29E3I11

About Aker BioMarine

Company Description

Aker BioMarine was created because of our strong belief in the positive health effects of krill. More than a decade later, our business continues to grow because we take care of the ecosystem we harvest in. To us, it makes no sense to take something out of the ocean to improve our health, if it simultaneously compromises the health of the ocean. Ensuring the well-being of the krill biomass and contributing towards a thriving Antarctic ecosystem are among our core priorities.

The unique phospholipid-bound omega-3s in krill can help reduce the risk of several lifestyle diseases, including heart and brain-related issues. Aker BioMarine has taken on a global challenge to raise awareness about the importance of omega-3s. In 2020, 1,6 billion doses of Superba Krill were sold worldwide, improving the health of millions of people.

Year founded


Served area



Oksenøyveien 10, 1327 Lysaker – Norway

Filings & Publications

Shareholder information

Shares outstanding



July 6, 2020

Stock exchange(s)

Euronext Oslo



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.